Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
46,691,176
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
18,780,707
-
Shares change
-
+2,609,786
-
Total reported value, excl. options
-
$504,776,012
-
Value change
-
+$68,608,646
-
Number of buys
-
42
-
Number of sells
-
14
-
Price
-
$26.97
Institutional Holders of 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) as of Q3 2021
As of 30 Sep 2021 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) had 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,780,707 shares of stock of the company.
Largest 10 holders included VIKING GLOBAL INVESTORS LP, BVF INC/IL, JANUS HENDERSON GROUP PLC, BlackRock Inc., Casdin Capital, LLC, Aquilo Capital Management, LLC, FMR LLC, ArrowMark Colorado Holdings LLC, VANGUARD GROUP INC, and Octagon Capital Advisors LP.
This table shows 67 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.